Aviatrix, the innovative company renowned for its exceptional wall frescoes crafted from the finest quality German Vlies, has successfully raised an impressive $2 billion in its latest funding round. Founded by the talented duo Gabriela Tylesova and Emelia Simcox, who draw inspiration from rich traditions of theatrical and visual arts, Aviatrix has set itself apart in the home decor industry by utilizing cutting-edge digital print technology to create stunning and immersive wall art. This significant infusion of capital will be geared toward expanding the company's product offerings, enhancing its production capabilities, and solidifying its position within the competitive interior design market. With a commitment to quality and artistry, Aviatrix aims to reach new heights by broadening its design portfolio, allowing customers to transform their spaces into breathtaking environments that tell a story. The funding will enable the company to invest in research and development, ensuring continuous innovation in both design and printing technology, while also establishing a stronger online presence to engage clients and expand their market reach. As Aviatrix embarks on this exciting journey, it remains dedicated to preserving the aesthetic integrity and emotional resonance of its artworks, reflecting the creators' passion for art and design. With this monumental backing, the future looks bright for Aviatrix, as it continues to transform spaces with its unique and compelling visual narratives.
Aviatrix Takes Flight with $2 Billion Investment to Revolutionize Wall Fresco Printing Technology
Get the full Aviatrix company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Beeline Medicines
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. We are here to chart a new path for patients, rigorously pushing the science forward to deliver therapies that go straight to the drivers of immune dysfunction to define new treatment paradigms. Our portfolio is comprised of therapeutic candidates rooted in validated biology, powered by best-in-class molecular properties, and driven by an efficient clinical development strategy designed for differentiated, lasting impact for patients. Grounded in scientific rigor and driven by purpose, we get to what matters so that people living with immune-mediated diseases can live life fully.
$126.3M Series a
today
Revoraai
Most real estate businesses don’t have a lead problem. They have a conversion problem. Leads come in… But slow replies, missed follow-ups, and unqualified inquiries kill deals. That’s where I help. I build AI-powered systems that: • Instantly respond to new leads • Filter serious buyers • Follow up automatically • Turn conversations into site visits No manual chasing. No missed opportunities. Just a smarter way to convert leads into revenue. If you're in real estate and want to automate your lead flow, let’s connect.
$2.0M Seed
today
LEKO
LEKO Labs is accelerating the global transition to carbon negative construction with building materials powered by AI optimization and robotic manufacturing.
$9.0M Seed
today
Wolf-e Robotics
EU Manufacturer of Smart #UVC Disinfection Devices. Air Purifiers, Applied UV Robotics, Research & Development Platform. Gausium cleaning robots distributor. Democratizing clean air and surfaces in any indoor space. For collabs & enquiries, check our website: www.wolfe.ro.
$54.0K Unknown
today
OxidOS Automotive
OxidOS Automotive is building the next generation of software development tools and Operating Systems for Automotive ECUs, fully written in Rust. The OxidOS platform and Operating System allow automotive manufacturers and integrators to deploy safe and secure software faster, through development, debugging, and certification time reduction.
$54.0K Unknown
today